You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML in Remission

Showing 1 - 25 of 4,625
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • AML
  • DC AML Vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 25, 2022

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Boston, Massachusetts
  • +5 more
Oct 21, 2022

AML Patients After Stem Cell Transplant to Understand Relapse

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
  • Duarte, California
  • +3 more
Dec 7, 2022

Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

Completed
Has Results
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 18, 2022

Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Milano, Lombardia, Italy
    Ospedale San Raffaele
Jul 18, 2022

Acute Myeloid Leukemia (AML) in Remission Trial in Washington (CPX-351)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
May 3, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

AML Trial in Moscow (allo-HSCT)

Recruiting
  • AML
  • allo-HSCT
  • Moscow, Russian Federation
    National Research Center for Hematology
Apr 14, 2022

Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)

Completed
  • Acute Myeloid Leukemia
  • HAM
  • LDAC and/or Mitoxantrone
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +17 more
Aug 2, 2022

Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

Not yet recruiting
  • Acute Myeloid Leukemia in Remission
  • Nantes, Loire Atlantique, France
  • +22 more
Jun 15, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 10, 2022

Acute Myeloid Leukemia Trial in Pittsburgh (pembrolizumab)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
Jul 16, 2021

Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Center
Apr 4, 2022

Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

Recruiting
  • Acute Myeloid Leukemia
  • Decitabine and Cedazuridine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Acute Myeloid Leukemia in Remission Trial in Nanjing (Azacitidine, Lenalidomide)

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Acute Myeloid Leukemia Trial in Italy (Vidaza 100 milligram (mg) injection, Best Supportive Care)

Completed
  • Acute Myeloid Leukemia
  • Vidaza 100 milligram (mg) injection
  • Best Supportive Care
  • Alessandria, AL, Italy
  • +17 more
Jan 13, 2022

Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Stem Cell Transplantation
  • busulfan, cyclophosphamide and melphalan, BuCyMel
  • clofarabine, fludarabine and busulfan, CloFluBu
  • Brussels, Belgium
  • +16 more
Jul 25, 2022

Acute Myeloid Leukemia in Remission, MDS, Minimal Residual Disease Trial in Germany (Pevonedistat, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia in Remission
  • +2 more
  • Aachen, Germany
  • +13 more
Jul 11, 2022

Acute Myeloid Leukemia Trial in Japan (Oral Azacitidine, Placebo)

Recruiting
  • Acute Myeloid Leukemia
  • Oral Azacitidine
  • Placebo
  • Nagoya, Aichi, Japan
  • +30 more
May 25, 2022